The National Pharmaceutical Pricing Authority (NPPA) has given green signal to six major manufacturers to export 50 per cent of their monthly operating capacity of paracetamol active pharmaceutical ingredient (API) subject to release of similar quantity for domestic market.

The manufacturers-- Farmson Pharmaceuticals, Meghmani LLP, Sri Krishna Pharmaceuticals, Granules India Ltd, Bharat Chemicals and Para Products Pvt Ltd--are required to submit an undertaking to Directorate General of Foreign Trade (DGFT) in this regard at the time of export.

Source: pharmabiz.com